Newsroom

News

WALK101's latest news, organized by date.

Platum Article Thumbnail
2025.12.22

CNTTech 'Early Startup Package Rocketship IR Competition' Demo Day... WALK101 Wins Grand Prize

At a demo day hosted by CNTTech, WALK101 won the Grand Prize for its AI-based bone and joint X-ray reading assistance software.

Forbes Korea Article Thumbnail
2025.12.11

KOICA CTS ‘SEED 0’ Final 25 Teams Announced... Including WALK101

The final selected teams for KOICA CTS ‘SEED 0’ were revealed, and WALK101 was included in the list.

Kihoilbo Article Thumbnail
2025.12.09

Incheon Center for Creative Economy & Innovation, ‘Startup Pathfinder Competition’ Awards and Performance Sharing... WALK101 Wins Grand Prize

The Incheon Center for Creative Economy & Innovation held an awards ceremony and performance sharing session for the '2025 Startup Pathfinder Competition' to honor excellent startups. WALK101 was named for the Grand Prize.

Platum Investment Article Thumbnail
2025.12.05

MYSC Executes Seed Investment in AI Medical Solution ‘WALK101’... Connected to TIPS Selection

MYSC executed a seed investment in WALK101, which is expected to accelerate technology advancement and global expansion through the recommendation resulting in TIPS selection.

2025 Startup Pathfinder Orientation Image
2025.06.27

Incheon Center for Creative Economy & Innovation Successfully Concludes orientation for ‘Startup Pathfinder’ 2025

The Incheon Center for Creative Economy & Innovation held an orientation for the '2025 Startup Pathfinder', sharing the direction of support program operations with the selected companies.

Segye Article Thumbnail
2025.03.05

‘AI Medical Device Development’ WALK101 Obtains MFDS GMP

WALK101 obtained GMP (Medical Device Manufacturing and Quality Control Standards) certification from the MFDS, establishing a quality management system that allows them to directly develop and produce software medical devices. The company plans to fully expand its AI SaMD lineup in the healthcare sector and technical commercialization in the future.